Ionis Pharmaceuticals (IONS) Payables (2009 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Payables of $47.7 million for Q2 2026, up 109.23% year-over-year from $22.8 million in Q2 2025, and up 83.27% quarter-over-quarter from $26.0 million in Q1 2026.
Ionis Pharmaceuticals (IONS) Payables (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Payables history runs 18 years deep, the most recent figure standing at $47.7 million for Q2 2026.
- In Q2 2026, Payables rose 109.23% year-over-year to $47.7 million; the TTM figure through Jun 2026 stood at $47.7 million (up 109.23% YoY), while the FY2025 annual figure was $28.1 million, down 34.64% from the prior year.
- Payables for Q2 2026 stood at $47.7 million, up from $26.0 million in the prior quarter.
- The five-year high for Payables was $47.7 million in Q2 2026, with the low at $5.6 million in Q3 2023.
- The 5-year median for Payables is $17.7 million (2022), against an average of $20.1 million.
- The sharpest annual moves came in 2023 and 2025: Payables tumbled 72.67% in 2023, then surged 146.67% in 2025.
- Ionis Pharmaceuticals' Payables stood at $17.9 million in 2022, then jumped by 45.23% to $26.0 million in 2023, then surged by 65.07% to $43.0 million in 2024, then slumped by 34.64% to $28.1 million in 2025, then jumped by 69.87% to $47.7 million in 2026.
- Business Quant data shows IONS's Payables at $47.7 million in Q2 2026, $26.0 million in Q1 2026, and $28.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | 47.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.70 Mn |
| Mar 31, 2026 | 26.03 Mn |
| Dec 31, 2025 | 28.08 Mn |
| Sep 30, 2025 | 14.33 Mn |
| Jun 30, 2025 | 22.80 Mn |
| Mar 31, 2025 | 17.46 Mn |
| Dec 31, 2024 | 42.96 Mn |
| Sep 30, 2024 | 9.05 Mn |
| Jun 30, 2024 | 9.24 Mn |
| Mar 31, 2024 | 13.08 Mn |
| Dec 31, 2023 | 26.03 Mn |
| Sep 30, 2023 | 5.62 Mn |
| Jun 30, 2023 | 24.02 Mn |
| Mar 31, 2023 | 10.50 Mn |
| Dec 31, 2022 | 17.92 Mn |
| Sep 30, 2022 | 20.55 Mn |
| Jun 30, 2022 | 10.35 Mn |
| Mar 31, 2022 | 16.13 Mn |
| Dec 31, 2021 | 11.90 Mn |
| Sep 30, 2021 | 8.36 Mn |